Author Question: When the internal consistency of a test is being determined on the basis of the Kuder-Richardson ... (Read 107 times)

Sufayan.ah

  • Hero Member
  • *****
  • Posts: 512
When the internal consistency of a test is being determined on the basis of
  the Kuder-Richardson formula (KR21), then it should NOT be followed by
 
  a. any attempts to determine predictive validity
  b. any attempts to determine concurrent validity
  c. the Spearman-Brown prophecy formula
  d. none of these, since the KR21 is NOT an internal consistency measure

Question 2

In a two-way 2, N can be found by
 
  a. adding all observed frequencies.
  b. adding row total observed frequencies.
  c. adding column total observed frequencies.
  d. All of the above are correct.



sarahccccc

  • Sr. Member
  • ****
  • Posts: 318
Answer to Question 1

c

Answer to Question 2

d



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Drug-induced pharmacodynamic effects manifested in older adults include drug-induced renal toxicity, which can be a major factor when these adults are experiencing other kidney problems.

Did you know?

There can actually be a 25-hour time difference between certain locations in the world. The International Date Line passes between the islands of Samoa and American Samoa. It is not a straight line, but "zig-zags" around various island chains. Therefore, Samoa and nearby islands have one date, while American Samoa and nearby islands are one day behind. Daylight saving time is used in some islands, but not in others—further shifting the hours out of sync with natural time.

Did you know?

Essential fatty acids have been shown to be effective against ulcers, asthma, dental cavities, and skin disorders such as acne.

Did you know?

The modern decimal position system was the invention of the Hindus (around 800 AD), involving the placing of numerals to indicate their value (units, tens, hundreds, and so on).

Did you know?

Computer programs are available that crosscheck a new drug's possible trade name with all other trade names currently available. These programs detect dangerous similarities between names and alert the manufacturer of the drug.

For a complete list of videos, visit our video library